Loading...
Docoh

Apyx Medical (APYX)

Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people's lives through innovative products in the cosmetic and surgical markets. Known for its innovative Helium Plasma Technology, Apyx is solely focused on bringing transformative solutions to the physicians and patients it serves. The company's Helium Plasma Technology is marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. Renuvion offers surgeons and physicians a unique ability to provide controlled heat to the tissue to achieve their desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminating unintended tissue trauma. The Company also leverages its deep expertise and decades of experience in unique waveforms through original equipment manufacturing (OEM) agreements with other medical device manufacturers.

Company profile

Ticker
APYX
Exchange
Website
CEO
Robert Gershon
Employees
Incorporated
Location
Fiscal year end
Former names
AN CON GENETICS INC, BOVIE MEDICAL CORP, BOVIE MEDICAL Corp
SEC CIK
Subsidiaries
Apyx China Holding Corp. ...
IRS number
112644611

APYX stock data

Analyst ratings and price targets

Last 3 months

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

12 May 22
9 Aug 22
31 Dec 22
Quarter (USD) Mar 22 Dec 21 Sep 21 Jun 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 26.23M 26.23M 26.23M 26.23M 26.23M 26.23M
Cash burn (monthly) 1.55M 1.11M 1.97M 1.33M 1.51M 1.08M
Cash used (since last report) 6.65M 4.77M 8.46M 5.73M 6.48M 4.63M
Cash remaining 19.58M 21.46M 17.77M 20.5M 19.75M 21.6M
Runway (months of cash) 12.7 19.4 9.0 15.4 13.1 20.1

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
11 Jul 22 Waldman Lawrence Common Stock Option exercise Acquire M No No 2.54 24,000 60.96K 37,563
11 Jul 22 Waldman Lawrence Stock Option (Option to Buy) Common Stock Option exercise Dispose M No No 2.54 24,000 60.96K 0
11 Jul 22 Moshe Citronowicz Common Stock Option exercise Acquire M No No 2.54 30,000 76.2K 456,504
11 Jul 22 Moshe Citronowicz Stock Option (Option to Buy) Common Stock Option exercise Dispose M No No 2.54 30,000 76.2K 0
6 Jul 22 Michael Geraghty Common Stock Option exercise Acquire M No No 2.54 4,000 10.16K 17,500
6 Jul 22 Michael Geraghty Stock Option (Option to Buy) Common Stock Option exercise Dispose M No No 2.54 4,000 10.16K 0
5 Jul 22 Andrew Makrides Common Stock Payment of exercise Dispose F No No 6.14 13,583 83.4K 624,389
5 Jul 22 Andrew Makrides Common Stock Option exercise Acquire M No No 2.54 30,000 76.2K 637,972
5 Jul 22 Andrew Makrides Stock Option (Option to Buy) Common Stock Option exercise Dispose M No No 2.54 30,000 76.2K 0
19 May 22 Waldman Lawrence Common Stock Option exercise Acquire M No No 2.79 8,000 22.32K 13,563
13F holders Current Prev Q Change
Total holders 0 0
Opened positions 0 0
Closed positions 0 0
Increased positions 0 0
Reduced positions 0 0
13F shares Current Prev Q Change
Total value 0 0
Total shares 0 0
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners Shares Value Change
Largest transactions Shares Bought/sold Change

Financial report summary

?
Competition
MedtronicConmedMedtronicInmode
Management Discussion
  • ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
  • You should read the following discussion and analysis in conjunction with our financial statements and related notes contained elsewhere in this report. This discussion contains forward-looking statements that involve risks, uncertainties and assumptions. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors discussed in this report and those discussed in other documents we file with the SEC. In light of these risks, uncertainties and assumptions, readers are cautioned not to place undue reliance on such forward-looking statements. These forward-looking statements represent beliefs and assumptions as of the date of this report. While we may elect to update forward-looking statements and at some point in the future, we specifically disclaim any obligation to do so, even if our estimates change. Past performance does not guarantee future results.
  • We are an advanced energy technology company with a passion for elevating people’s lives through innovative products, including our Helium Plasma Technology products marketed and sold as Renuvion® and J-Plasma® in surgical markets. We are solely focused on bringing transformative solutions to physicians and their patients. Renuvion® and J-Plasma® offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. We also leverage our deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers.

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: ablation, alleging, care, carrier, citing, clearance, coagulation, cutting, Drug, economy, evolve, FDA, Food, fully, improper, inflationary, instability, laparoscopic, lapse, lax, letter, loose, matter, minimize, neck, notification, offer, open, optimal, payroll, posted, premarket, relieved, securing, skin, soft, statute, submental, termination, volume
Removed: accurately, adequate, advantage, assessment, auditing, automated, capacity, carryforward, challenging, close, collaborative, confidence, consumer, contact, continuing, cosmetic, curtail, declined, decreased, delaying, depend, difficult, discretionary, disposition, distancing, duration, ease, efficiency, eliminating, emerge, enhance, enterprise, environment, ERP, exposure, extensively, faced, fascial, flow, forego, foreseeable, forming, goal, government, Governmental, half, headcount, high, hiring, hospital, identified, implementation, implemented, implementing, imposing, improved, improvement, improving, inherent, introduction, key, largely, law, limit, liquidity, Maintaining, manage, mind, mitigated, modified, navigate, occurred, operated, optimistic, order, ordered, original, outbreak, paid, permanently, personal, planning, plastic, Policy, pose, positively, potentially, precision, predict, predicted, preemptive, prevent, preventative, prospective, protect, Protecting, protective, public, put, reach, receipt, recovery, reducing, reinstate, release, relief, rely, remain, remediation, remotely, replaced, require, requiring, resource, restrict, sharpen, significantly, site, situation, slower, sluggish, social, source, split, spread, strain, strong, subsequently, summarize, surgeon, surgery, system, target, trauma, Treasury, type, unintended, unknown, unpredictable, virtual, virtually, world, yield